These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antineutrophil cytoplasmic autoantibodies-antigen specificity and associated diseases. Vizjak A; Nagode B; Rott T; Koselj M; Rozman B; Kaplan-Pavlovcic S; Kosnik M; Petric V; Ferluga D Wien Klin Wochenschr; 2000 Aug; 112(15-16):665-70. PubMed ID: 11020953 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis of vasculitis. Mohan N; Kerr GS Best Pract Res Clin Rheumatol; 2001 Jun; 15(2):203-23. PubMed ID: 11469818 [TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive therapy of vasculitis: current aspects and perspectives]. Giacomelli R; Pizzuto F; Cucinelli F; Tonietti G Recenti Prog Med; 1996 Mar; 87(3):124-34. PubMed ID: 8650433 [TBL] [Abstract][Full Text] [Related]
8. [Diffuse pulmonary hemorrhage associated with antineutrophil cytoplasmic antibodies. Findings of high-resolution computerized tomography. A case report]. Galeotti R; Sala S; Rosina G; Mannella P Radiol Med; 1997 Dec; 94(6):685-7. PubMed ID: 9524614 [No Abstract] [Full Text] [Related]
9. Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group. Jayne DR; Rasmussen N Mayo Clin Proc; 1997 Aug; 72(8):737-47. PubMed ID: 9276602 [TBL] [Abstract][Full Text] [Related]
10. Streptococcal viridans subacute bacterial endocarditis associated with antineutrophil cytoplasmic autoantibodies (ANCA). de Corla-Souza A; Cunha BA Heart Lung; 2003; 32(2):140-3. PubMed ID: 12734537 [TBL] [Abstract][Full Text] [Related]
11. 4. Antineutrophil cytoplasmic antibody (ANCA) associated vasculitis: from molecular analysis to bedside. Yoshida M Intern Med; 2002 Jan; 41(1):47-9. PubMed ID: 11838592 [No Abstract] [Full Text] [Related]
12. [Neurological manifestations of systemic necrotizing vasculitis]. Said G Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):915-8. PubMed ID: 12407299 [TBL] [Abstract][Full Text] [Related]
13. Opportunistic infections are preceded by a rapid fall in antineutrophil cytoplasmic antibody (ANCA) titer in patients with ANCA associated vasculitis. Palsson R; Choi HK; Niles JL J Rheumatol; 2002 Mar; 29(3):505-10. PubMed ID: 11908563 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic study of intractable vasculitis]. Abe T Nihon Rinsho; 1994 Aug; 52(8):2169-72. PubMed ID: 7933606 [TBL] [Abstract][Full Text] [Related]
16. [Approach to the diagnosis and therapy of vascular neuropathy]. Hernández MA; Caminero AB Rev Neurol; 1995; 23(123):1008-12. PubMed ID: 8556583 [TBL] [Abstract][Full Text] [Related]
17. Hemorrhagic stroke due to cerebral vasculitis and the role of immunosuppressive therapy. Cohen BA; Biller J Neurosurg Clin N Am; 1992 Jul; 3(3):611-24. PubMed ID: 1633484 [TBL] [Abstract][Full Text] [Related]
18. [Initial results of multicenter, randomized, controlled therapy studies of ANCA-associated vasculitis]. De Groot K Z Rheumatol; 2002 Oct; 61(5):607-9. PubMed ID: 12399892 [No Abstract] [Full Text] [Related]
19. [Steroid and non-steroidal anti-inflammatory drug therapy of vasculitis]. Abe T Nihon Rinsho; 1994 Aug; 52(8):2173-6. PubMed ID: 7933607 [TBL] [Abstract][Full Text] [Related]
20. Anti-neutrophil cytoplasmic antibodies: tools for diagnosis and follow-up in systemic vasculitis. Stegeman CA; Tervaert JW; Kallenberg CG Ann Med Interne (Paris); 1994; 145(8):523-32. PubMed ID: 7710178 [No Abstract] [Full Text] [Related] [Next] [New Search]